click on circles to display study description...

Ghandehari, 2020 NCT04365127

progesterone (n=20) vs. standard of care (n=22)

randomized controlled trial

subcutaneous progesterone
progesterone (100 mg subcutaneously twice daily for up to 5 days) plus SOC

SOC alone

COVID-19 mild to moderate

open-label

Cedars Sinai Medical Center, Los Angeles, USA